Cargando…

Successful treatment of recurrent small cell carcinoma of urinary bladder with pembrolizumab

INTRODUCTION: Small cell carcinoma of urinary bladder is rare and has an aggressive malignant behavior and poor prognosis. Advanced bladder cancers are treated with immune checkpoint inhibitors, however, its efficacy for small cell carcinoma of urinary bladder is unclear. CASE PRESENTATION: A 54‐yea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatayama, Tomoya, Hayashi, Tetsutaro, Matsuzaki, Shinji, Masumoto, Hiroshi, Yanai, Hiroyuki, Abdi, Hamidreza, Teishima, Jun, Hasegawa, Yasuhisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609171/ https://www.ncbi.nlm.nih.gov/pubmed/33163917 http://dx.doi.org/10.1002/iju5.12208

Ejemplares similares

Editorial Comment to Progressive plasmacytoid variant bladder cancer with retroperitoneal dissemination: An autopsy case report
por: Hayashi, Tetsutaro, et al.
Publicado: (2020)

Evaluation of urinary catheters for effective manual bladder washout
por: Kobatake, Kohei, et al.
Publicado: (2022)

Refractory fistula of bladder repaired with transurethral cystoscopic injection of N‐butyl‐2‐cyanoacrylate
por: Mukai, Sakurako, et al.
Publicado: (2019)

Successful Response of Pembrolizumab Rechallenge after Radiotherapy for a Patient with Bladder Cancer of Nonresponse of Pembrolizumab First Challenge
por: Ikeda, Taro, et al.
Publicado: (2021)

Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy
por: Teishima, Jun, et al.
Publicado: (2021)

Pneumatosis cystoides intestinalis linked to sunitinib treatment for renal cell carcinoma
por: Shikuma, Hiroyuki, et al.
Publicado: (2019)

Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor
por: Teishima, Jun, et al.
Publicado: (2021)

Effect of penile rehabilitation with low intensity extracorporeal shock wave therapy on erectile function recovery following robot-assisted laparoscopic prostatectomy
por: Inoue, Shogo, et al.
Publicado: (2020)

Change of preoperative symptoms of the late-onset hypogonadism syndrome after robot-assisted radical prostatectomy
por: Teishima, Jun, et al.
Publicado: (2021)

Successful treatment of metastatic bladder pleomorphic giant cell carcinoma with pembrolizumab
por: Nezu, Kunihisa, et al.
Publicado: (2021)

Recurrent Urinary Bladder Paraganglioma
por: Al-Zahrani, Ali A.
Publicado: (2010)

Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma
por: Teishima, Jun, et al.
Publicado: (2023)

KIFC1 Is Associated with Basal Type, Cisplatin Resistance, PD-L1 Expression and Poor Prognosis in Bladder Cancer
por: Sekino, Yohei, et al.
Publicado: (2021)

Successful treatment of BK virus‐associated severe hemorrhagic cystitis with bilateral single‐J ureteral stenting
por: Fujita, Akira, et al.
Publicado: (2022)

Successful treatment of metastatic bladder cancer by gemcitabine‐cisplatin re‐challenge after pembrolizumab
por: Arai, Takayuki, et al.
Publicado: (2021)

Endoscopic repair of the urinary bladder with magnetically labeled mesenchymal stem cells: Preliminary report
por: Sadahide, Kosuke, et al.
Publicado: (2018)

Case of renal mucinous tubular and spindle cell carcinoma with high nuclear grade
por: Hatayama, Tomoya, et al.
Publicado: (2019)

AB171. Regeneration of rat corpus cavernosa tissue after transplantation of human bone-marrow-derived CD133(+) cells
por: Inoue, Shogo, et al.
Publicado: (2015)

Inguinal Herniation of the Urinary Bladder Presenting as Recurrent Urinary Retention
por: Frenkel, Amit, et al.
Publicado: (2015)

Postoperative around-the-clock administration of intravenous acetaminophen for pain control following robot-assisted radical prostatectomy
por: Inoue, Shogo, et al.
Publicado: (2021)

Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis
por: Ishii, Akiko, et al.
Publicado: (2020)

Corrigendum to “Inguinal Herniation of the Urinary Bladder Presenting as Recurrent Urinary Retention”
por: Frenkel, Amit, et al.
Publicado: (2019)

Urothelial Damage and Tumor Initiation by Urinary Metabolites of Sodium o‐Phenylphenate in the Urinary Bladder of Female Rats
por: Hasegawa, Ryohei, et al.
Publicado: (1990)

Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab
por: Kobayashi, Takashi, et al.
Publicado: (2020)

Fibroblast Growth Factor Family in the Progression of Prostate Cancer
por: Teishima, Jun, et al.
Publicado: (2019)

Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer
por: Kai, Yugo, et al.
Publicado: (2021)

Bladder rupture after pembrolizumab immunotherapy for bladder cancer: a case report
por: Badheeb, Ahmed, et al.
Publicado: (2022)

Successful management of pelvic recurrence of MSI-High endometrial cancer by total pelvic exenteration followed by administration of pembrolizumab: A case report
por: Kojima, Manabu, et al.
Publicado: (2022)

PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non‐muscle‐invasive bladder cancer
por: Woodcock, Victoria K., et al.
Publicado: (2023)

Emergence of undifferentiated urothelial carcinoma after pembrolizumab treatment for patient with invasive urothelial bladder cancer: A case report
por: Hasegawa, Moto, et al.
Publicado: (2020)

Overexpression of claspin promotes docetaxel resistance and is associated with prostate‐specific antigen recurrence in prostate cancer
por: Babasaki, Takashi, et al.
Publicado: (2021)

Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study
por: Vermeulen, S H, et al.
Publicado: (2015)

Spontaneous bladder rupture diagnosis based on urinary appearance of mesothelial cells: a case report
por: Hayashi, Waka, et al.
Publicado: (2014)

Combination therapy using molecular‐targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma
por: Kitano, Hiroyuki, et al.
Publicado: (2017)

Modifying factors in urinary bladder carcinogenesis
por: Ito, Nobuyuki, et al.
Publicado: (1983)

Peritoneal Recurrence of Cecal Cancer with Specific Imaging Findings and Shrinkage after Treatment with Pembrolizumab
por: Takeda, Tomohiro, et al.
Publicado: (2022)

In situ Freezing of the Rat Urinary Bladder: DNA Adduct Formation in the Bladder Epithelium Demonstrated by (32)P‐Postlabeling Assay
por: Hasegawa, Ryohei, et al.
Publicado: (1989)

HOXB5 Overexpression Is Associated with Neuroendocrine Differentiation and Poor Prognosis in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2021)

Pattern of disease and response to pembrolizumab in recurrent cervical cancer
por: Miller, Kathryn M., et al.
Publicado: (2021)

Recurrent Erythema Multiforme Induced by the Combination of Pembrolizumab and Radiation
por: Ambur, Austin B, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aple05j3hmaukbpvci9qav3i4n